Postoperative care and follow-up after coronary stenting;Patienten nach koronarer stentimplantation nachsorge und verlaufsbeobachtung

Deutsches Arzteblatt International

Volumn 110, Issue 5, 2013, Pages 72-82

  Rassaf, Tienush ^a   Steiner, Stephan ^a   Kelm, Malte ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANAMNESIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY STENT; CORONARY STENTING; DISEASE COURSE; EXERCISE TEST; FOLLOW UP; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; HOSPITAL DISCHARGE; HUMAN; ISCHEMIC HEART DISEASE; PATIENT COUNSELING; PERCUTANEOUS CORONARY INTERVENTION; PHYSICAL EXAMINATION; POSTOPERATIVE CARE; RESTENOSIS; SILENT MYOCARDIAL ISCHEMIA; STENT THROMBOSIS; BLOOD VESSEL PROSTHESIS; CORONARY ARTERY DISEASE; HEART FUNCTION TEST; PROCEDURES; STENT;

BLOOD VESSEL PROSTHESIS; CORONARY ARTERY DISEASE; HEART FUNCTION TESTS; HUMANS; PHYSICAL EXAMINATION; POSTOPERATIVE CARE; STENTS;

EID: 84906329121     PISSN: 18660452     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2013.0072     Document Type: Article

References (49)

1. van Buuren F: 25. Bericht über die Leistungszahlen der Herzkatheterlabore in der Bundesrepublik Deutschland. Kardiologe 2010; 4: 502-8.
2. Hamm CW, Albrecht A, Bonzel T, et al.: Diagnostic heart catheterization. Clin Res Cardiol 2008; 97: 475-512.
3. Levine GN, Bates ER, Blankenship JC, et al.: 2011 ACCF/AHA/ SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011; 124: e574-e651.
4. Wijns W, Kolh P, Danchin N, et al.: Guidelines on myocardial revascularization. Eur Heart J 2010; 31: 2501-55.
5. Bonzel T, Erbel R, Hamm CW, et al.: Percutaneous coronary interventions (PCI). Clin Res Cardiol 2008; 97: 513-47.
6. Donner-Banzhoff N, Held K, Laufs U, Trappe H-J, Werdan K, Zerkowski HR: Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Chronisch KHK. Version 1.12, Available from: www.khk.versorgungsleitlinien.de . Last accessed on 1 December 2012.
7. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115-26.
8. Guyton JR: Clinical assessment of atherosclerotic lesions: emerging from angiographic shadows. Circulation 2002; 106: 1308-9.
9. Celermajer DS: Noninvasive detection of atherosclerosis. N Engl J Med 1998; 339: 2014-5.
10. Gibbons RJ, Abrams J, Chatterjee K, et al.: ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 2003; 107: 149-58.
11. Nissen SE, Tuzcu EM, Schoenhagen P, et al.: Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 2005; 352: 29-38.
12. Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al.: Comparative effectiveness of revascularization strategies. N Engl J Med 2012; 366: 1467-76.
13. Russ M, Werdan K, Cremer J, et al.: Different treatment options in chronic coronary artery disease: when is it the time for medical treatment, percutaneous coronary intervention or aortocoronary bypass surgery? Dtsch Arztebl Int 2009; 106(15): 253-61.
14. st edition. Darmstadt: Steinkopff Verlag, 2009.
15. Gibbons RJ, Balady GJ, Bricker JT, et al.: ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol 2002; 40: 1531-40.
16. Cohn PF, Fox KM, Daly C: Silent myocardial ischemia. Circulation 2003; 108: 1263-77.
17. Fischman DL, Leon MB, Baim DS, et al.: A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994; 331: 496-501.
18. Serruys PW, de Jaegere P, Kiemeneij F, et al.: A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331: 489-95.
19. Moses JW, Leon MB, Popma JJ, et al.: Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-23.
20. Kirtane AJ, Gupta A, Iyengar S, et al.: Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation 2009; 119: 3198-206.
21. Chen MS, John JM, Chew DP, et al.: Bare metal stent restenosis is not a benign clinical entity. Am Heart J 2006; 151: 1260-4.
22. Mishkel GJ, Moore AL, Markwell S, et al.: Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents. J Am Coll Cardiol 2007; 49: 181-4.
23. Stolker JM, Kennedy KF, Lindsey JB, et al.: Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry. Circ Cardiovasc Interv 2010; 3: 327-34.
24. Singh M, Gersh BJ, McClelland RL, et al.: Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the Prevention of Restenosis With Tranilast and Its Outcomes (PRESTO) trial. Circulation 2004; 109: 2727-31.
25. Schwalm T: Transcarpal cardiac catheterization. Dtsch Arztebl Int 2009; 106(42): 685-91.
26. Mangiapane S, Busse R: Prescription prevalence and continuing medication use for secondary prevention after myocardial infarc -tion: the reality of care revealed by claims data analysis. Dtsch Arztebl Int 2011; 108(50): 856-62.
27. Scanlon PJ, Faxon DP, Audet AM, et al.: ACC/AHA guidelines for coronary angiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions. Circulation 1999; 99: 2345-57.
28. Hamm CW, Bassand JP, Agewall S, et al.: ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients pre -senting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 2999-3054.
29. Wright RS, Anderson JL, Adams CD, et al.: 2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011; 57: 1920-59.
30. George JC, Dangas GD: 2009 Focused updates to guidelines in ST-elevation myocardial infarction and percutaneous coronary intervention: application to interventional cardiology. JACC Cardiovasc Interv 2010; 3: 256-8.
31. Smith SC Jr, Feldman TE, Hirshfeld JW Jr., et al.: ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006; 113: e166-e286.
32. Cheitlin MD, Armstrong WF, Aurigemma GP, et al.: ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation 2003; 108: 1146-62.
33. Klocke FJ, Baird MG, Lorell BH, et al.: ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation 2003; 108: 1404-18.
34. Lindner O, Rusche H, Schäfers M, et al.: Myocardial Perfusion SPECT Imaging: Current Concepts. Dtsch Ärztebl Int 2007; 104(14): 952-9.
35. Sarno G, Decraemer I, Vanhoenacker PK, et al.: On the inappropri -ateness of noninvasive multidetector computed tomography coronary angiography to trigger coronary revascularization: a comparison with invasive angiography. JACC Cardiovasc Interv 2009; 2: 550-7.
36. Shaw LJ, Berman DS, Maron DJ, et al.: Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008; 117: 1283-91.
37. Boden WE, O'Rourke RA, Teo KK, et al.: Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 1503-16.
38. Cannon CP, Braunwald E, McCabe CH, et al.: Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495-504.
39. Cutlip DE, Windecker S, Mehran R, et al.: Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007; 115: 2344-51.
40. Pinto DS, Stone GW, Ellis SG, et al.: Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial. J Am Coll Cardiol 2006; 48: 32-6.
41. Espinola-Klein C, Rupprecht HJ, Erbel R, et al.: Impact of restenosis 10 years after coronary angioplasty. Eur Heart J 1998; 19: 1047-53.
42. Schuhlen H, Kastrati A, Mehilli J, et al.: Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement. Am Heart J 2004; 147: 317-22.
43. Uchida T, Popma J, Stone GW, et al.: The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesions. JACC Cardiovasc Interv 2010; 3: 403-11.
44. Kushner FG, Hand M, Smith SC Jr., et al.: 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009; 54: 2205-41.
45. Scanlon PJ, Faxon DP, Audet AM, et al.: ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiol ogy/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 1999; 33: 1756-824.
46. Kushner FG, Hand M, Smith SC Jr., et al.: 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009; 54: 2205-41.
47. Taylor AJ, Cerqueira M, Hodgson JM, et al.: ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. Circulation 2010; 122: e525-e555.
48. Wijns W, Kolh P, Danchin N, et al.: Guidelines on myocardial revascularization. Eur Heart J 2010; 31: 2501-55.
49. Wright RS, Anderson JL, Adams CD, et al.: 2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011; 57: 1920-59.